Expiration Date: 10/09/2024
Learner Notification
Speaker
Franklin King IV, MD
Director of Training & Education
Massachusetts General Hospital
Moderator
James Whitledge, MD
Herbs and Dietary Supplements Section Co-Chair
University of Vermont Medical Center
Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Description
Toxicologists typically view psychedelics, including those that are plant-derived, from a pathologic perspective, as we frequently treat patients with toxicity after psychedelic exposure. However, psychedelic substances also represent a promising therapeutic frontier for the treatment of psychiatric disease, and in coming years psychedelic-based therapeutics may become more widely available. Toxicologists must be aware of the medicinal applications of psychedelics in addition to harms as the trend towards clinical applications of psychedelics continues. Dr. King will provide a 60-minute lecture on the therapeutic applications and benefits of psychedelics, in particular those that are plant-derived.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Objectives - After attending this program you should be able to:
- Describe the current state of psychedelic research.
- Identify the current therapeutic applications of psychedelics.
- Discuss expected future trends in psychedelics research and clinical applications.
Disclosure of Conflict of Interest